Vitiligo: Pathogenesis and Therapeutic Approaches

Overview / Definition Vitiligo is a chronic skin condition defined by the development of depigmented macules and patches on the skin due to the loss of melanocytes, the cells responsible for producing the pigment melanin. It can affect any area of the skin and may also involve hair and mucous membranes, leading to a distinctive appearance in affected individuals. Epidemiology Vitiligo affects approximately 0.5% to 2% of the global population, with varying prevalence across different ethnic groups. The onset is most common in individuals aged 10 to 30 years, but it can occur at any age. There is no gender predilection, although some studies suggest a slight female predominance. Prevalence varies by region and ethnicity. Higher prevalence in individuals with autoimmune diseases. Pathophysiology / Mechanism The pathogenesis of vitiligo remains incompletely understood, but it is believed to involve an interplay of genetic, autoimmune, and environmental factors. Evidence suggests that autoimmunity plays a significant role, as vitiligo is often associated with other autoimmune disorders such as thyroid disease and pernicious anemia. Genetic predisposition: Variants in genes related to immune response. Environmental triggers: Sunburn, stress, and skin trauma. Autoimmune destruction of melanocytes. Clinical Presentation Patients with vitiligo typically present with well-defined, hypopigmented macules that may coalesce to form larger patches. These lesions can occur anywhere on the body, but commonly affect sun-exposed areas such as the face, hands, and extremities. The condition may be classified into two main types: Non-segmental vitiligo Segmental vitiligo: Follows a dermatomal distribution and is less common, often stable over time. Diagnosis / Workup The diagnosis of vitiligo is primarily clinical, based on the characteristic appearance of the skin lesions. However, the following steps may aid in confirming the diagnosis and ruling out other conditions: Clinical examina